N, performed the experiments; Jie Feng, Megan Weitner, David Sullivan, and
N, performed the experiments; Jie Feng, Megan Weitner, David Sullivan, and Ying Zhang analyzed the data; and Megan Weitner, Jie Feng, Ying Zhang wrote the paper. Conflicts of Interest The authors declare no conflict of interest. References 1. two. Centers for Disease Control and Prevention. Lyme Disease. TINAGL1 Protein web Offered on the internet: cdc.gov/lyme/ (accessed on 5 June 2015). Hinckley, A.F.; Connally, N.P.; Meek, J.I.; Johnson, B.J.; Kemperman, M.M.; Feldman, K.A.; White, J.L.; Mead, P.S. Lyme disease testing by substantial commercial laboratories within the United states. Clin. Infect. Dis. 2014, 59, 676sirtuininhibitor81. Radolf, J.D.; Caimano, M.J.; Stevenson, B.; Hu, L.T. Of ticks, mice and men: Understanding the dual-host life-style of lyme illness spirochaetes. Nat. Rev. Microbiol. 2012, ten, 87sirtuininhibitor9. Wormser, G.P.; Dattwyler, R.J.; Shapiro, E.D.; Halperin, J.J.; Steere, A.C.; Klempner, M.S.; Krause, P.J.; Bakken, J.S.; Strle, F.; Stanek, G.; et al. The clinical assessment, remedy, and prevention of lyme illness, human granulocytic anaplasmosis, and babesiosis: Clinical practice suggestions by the infectious illnesses society of america. Clin. Infect. Dis. 2006, 43, 1089sirtuininhibitor134. Centers for Illness Control and Prevention. Post Therapy Lyme Illness. Readily available on line: cdc.gov/lyme/postLDS (accessed on five June 2015). Adrion, E.R.; Aucott, J.; Lemke, K.W.; Weiner, J.P. Overall health care expenses, utilization and patterns of care following lyme illness. PLoS 1 2015, 10, e0116767. Aucott, J.N.; Rebman, A.W.; Crowder, L.A.; Kortte, K.B. Post-treatment lyme illness syndrome symptomatology plus the impact on life functioning: Is there anything theresirtuininhibitor Qual. Life Res. 2013, 22, 75sirtuininhibitor4. Phillips, S.E.; Mattman, L.H.; Hulinska, D.; Moayad, H. A proposal for the trusted culture of Borrelia burgdorferi from patients with chronic lyme disease, even from these previously aggressively treated. Infection 1998, 26, 364sirtuininhibitor67.three. four.5. six. 7.8.Antibiotics 2015, 4 9. ten.11. 12. 13.14. 15. 16. 17. 23.24.25.Barthold, S.W.; Hodzic, E.; Imai, D.M.; Feng, S.; Yang, X.; Luft, B.J. Ineffectiveness of tigecycline against persistent Borrelia burgdorferi. Antimicrob. Agents Chemother. 2010, 54, 643sirtuininhibitor51. Embers, M.E.; Barthold, S.W.; Borda, J.T.; Bowers, L.; Doyle, L.; Hodzic, E.; Jacobs, M.B.; Hasenkampf, N.R.; Martin, D.S.; Narasimhan, S.; et al. Persistence of Borrelia burgdorferi in Rhesus macaques following antibiotic therapy of disseminated infection. PLoS One particular 2012, 7, e29914. Hodzic, E.; Imai, D.; Feng, S.; Barthold, S.W. Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic therapy in mice. PLoS A single 2014, 9, e86907. Straubinger, R.K.; Summers, B.A.; Chang, Y.F.; Appel, M.J. Persistence of Borrelia burgdorferi in experimentally infected dogs following antibiotic remedy. J. Clin. Microbiol. 1997, 35, 111sirtuininhibitor16. Marques, A.; Telford, S.R., 3rd; Turk, S.P.; Chung, E.; Williams, C.; Dardick, K.; Krause, P.J.; Brandeburg, C.; Crowder, C.D.; TIM, Human (His) Carolan, H.E.; et al. Xenodiagnosis to detect Borrelia burgdorferi infection: A first-in-human study. Clin. Infect. Dis. 2014, 58, 937sirtuininhibitor45. Hodzic, E.; Feng, S.; Holden, K.; Freet, K.J.; Barthold, S.W. Persistence of Borrelia burgdorferi following antibiotic remedy in mice. Antimicrob. Agents Chemother. 2008, 52, 1728sirtuininhibitor736. Bayer, M.E.; Zhang, L.; Bayer, M.H. Borrelia burgdorferi DNA inside the uri.